NCT05037643View on ClinicalTrials.gov

Pre-emptive Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Cystic Fibrosis Related Liver Disease

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Cystic Fibrosis Liver DiseasePortal Hypertension Due to Cystic Fibrosis (Disorder)Portal Hypertension, Noncirrhotic
Interventions
PROCEDURE

TIPS

Transjugular Intrahepatic Portosystemic Shunt is performed to prevent / treat symptomatic portal hypertension

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT05037643 - Pre-emptive Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Cystic Fibrosis Related Liver Disease | Biotech Hunter | Biotech Hunter